Raj Prabhakar is a seasoned licensing and business development professional in the biotechnology industry. He serves as Senior Commercialization Officer for PATH Global Vaccine Development Program, based in Washington DC. PATH is a Seattle, WA based non-profit organization developing life-saving vaccines for the developing world.

Prior to joining PATH, Raj Prabhakar held leadership roles at Celsion Corporation for more than ten years, including Executive Director for Strategic Planning and Business Development in Princeton, New Jersey. At Celsion, Raj Prabhakar developed global development partnerships for the Asia Pacific Territories including China and Japan, the largest markets for liver cancer. Celsion is currently in global Phase III clinical trials for primary liver cancer.

Prior to Celsion Corporation, Raj Prabhakar held Director level positions at Osiris Therapeutics and Protiveris. Mr. Prabhakar holds a Masters in Business Administration from the Harvard Business School, and dual Bachelor of Science Degrees from the Massachusetts Institute of Technology.